Perspectives on Personalized Treatment in Difficult-to-Treat Depression: A Case Report
Abstract
Introduction: This case highlights the unique challenge of difficult-to-treat depression (DTD), a complex condition that distinguishes itself from treatment-resistant depression (TRD) due to its multifaceted nature. DTD is characterized by comorbidities, childhood trauma, symptomatic variability, personal history, substance use, and adherence issues, presenting a significant clinical challenge. Unlike TRD, typically defined by the failure of at least two adequate pharmacological treatments, DTD requires a more comprehensive approach. Recent literature supports a multidisciplinary treatment strategy as the most effective in managing DTD. The patient's main concerns and important clinical findings: We present the case of a 63-year-old female patient with a long-standing history of unresolved depressive disorder despite multiple pharmacological treatments. Her primary concerns included severe anhedonia, persistent suicidal ideation, and impaired personal and familial functioning. The patient's history included prior failed treatments, highlighting the complexity of her case. Primary diagnoses, interventions, and outcomes: The patient was diagnosed with DTD. A personalized treatment plan was implemented, integrating a clearly defined multidisciplinary approach: pharmacotherapy, psychotherapy (with a focus on grief and trauma processing), and psychosocial support, including active family involvement through psychoeducation sessions. Neurostimulation techniques were discussed as a…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Tryptophan Metabolism and Gut-Brain Homeostasis
- Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
- Prioritized Research for the Prevention, Treatment, and Reversal of Chronic Disease: Recommendations From the Lifestyle Medicine Research Summit
- Relationship between sleep disorders and gut dysbiosis: what affects what?
- The role of CLOCK gene in psychiatric disorders: Evidence from human and animal research
- Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer’s Disease
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.